The European drug delivery device market will see modest growth through 2027. Although the increasing availability of biosimilars will negatively impact ASPs, the greater affordability of lower-…
The Asia Pacific drug delivery device market will see moderate growth over the forecast period, fueled by the increasing availability of lower-cost generic drug delivery devices and the…
The Asia Pacific drug delivery device market will see moderate growth over the forecast period, fueled by the increasing availability of lower-cost generic drug delivery devices and the…
The US drug delivery device market will grow moderately through 2027, fueled by growth in patient populations and the approval of biosimilars for drug delivery devices. The opportunities…
The European drug delivery device market will see modest growth through 2027. Although the increasing availability of biosimilars will negatively impact ASPs, the greater affordability of lower-…